Emergent BioSolutions
EBS
#7753
Rank
โ‚ฌ0.22 B
Marketcap
4,14ย โ‚ฌ
Share price
3.96%
Change (1 day)
104.04%
Change (1 year)

Revenue for Emergent BioSolutions (EBS)

Revenue in 2024 (TTM): โ‚ฌ0.93 Billion

According to Emergent BioSolutions 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.88 Billion. an increase over the revenue in the year 2023 that were of โ‚ฌ0.92 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Emergent BioSolutions from 2004 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ0.97 B5.26%
2023 โ‚ฌ0.92 B-8.04%
2022 โ‚ฌ1.00 B-31.29%
2021 โ‚ฌ1.46 B25.06%
2020 โ‚ฌ1.17 B33.38%
2019 โ‚ฌ0.87 B42.4%
2018 โ‚ฌ0.61 B50.83%
2017 โ‚ฌ0.40 B24.47%
2016 โ‚ฌ0.32 B-8.74%
2015 โ‚ฌ0.35 B28.99%
2014 โ‚ฌ0.27 B49.37%
2013 โ‚ฌ0.18 B45.21%
2012 โ‚ฌ0.12 B-38.9%
2011 โ‚ฌ0.21 B-2.15%
2010 โ‚ฌ0.21 B31.29%
2009 โ‚ฌ0.16 B28.31%
2008 โ‚ฌ0.12 B1.95%
2007 โ‚ฌ0.12 B-4.43%
2006 โ‚ฌ0.13 B18.81%
2005 โ‚ฌ0.11 B79.24%
2004 โ‚ฌ61.55 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ56.23 B 6,230.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.12 B-86.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ35.21 B 3,864.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ6.15 M-99.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ55.76 B 6,177.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.49 B 1,532.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ0.1 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA